I
Ida Jeremiasen
Researcher at Lund University
Publications - 5
Citations - 44
Ida Jeremiasen is an academic researcher from Lund University. The author has contributed to research in topics: Sildenafil & Bronchopulmonary dysplasia. The author has an hindex of 1, co-authored 3 publications receiving 15 citations.
Papers
More filters
Journal ArticleDOI
Synchrotron-based phase-contrast micro-CT as a tool for understanding pulmonary vascular pathobiology and the 3-D microanatomy of alveolar capillary dysplasia
Christian Norvik,Christian Westöö,Niccolò Peruzzi,Goran Lovric,Goran Lovric,Oscar van der Have,Rajmund Mokso,Ida Jeremiasen,Hans Brunnström,Csaba Galambos,Martin Bech,Karin Tran-Lundmark +11 more
TL;DR: Dye injections generated a distinct attenuation difference between vessels and surrounding tissue, facilitating segmentation and three-dimensional rendering of pulmonary microvascular anatomy in paraffin-embedded tissue in synchrotron-based phase contrast micro-CT.
Journal ArticleDOI
Pulmonary Vasodilator Therapy in Children with Single Ventricle Physiology: Effects on Saturation and Pulmonary Arterial Pressure.
Ida Jeremiasen,Karin Tran-Lundmark,Nikmah S. Idris,Phan Kiet Tran,Shahin Moledina,Shahin Moledina +5 more
TL;DR: Pulmonary vasodilator therapy was well tolerated and associated with improvements in saturation and mean pulmonary arterial pressure in children with single ventricle physiology and it appears safe to discontinue when no clear benefit is observed.
Journal ArticleDOI
Distinct types of plexiform lesions identified by synchrotron-based phase-contrast micro-CT
Christian Westöö,Christian Norvik,Niccolò Peruzzi,Oscar van der Have,Goran Lovric,Goran Lovric,Ida Jeremiasen,Phan-Kiet Tran,Rajmund Mokso,Vinicio A. de Jesus Perez,Hans Brunnström,Martin Bech,Csaba Galambos,Karin Tran-Lundmark +13 more
TL;DR: In pulmonary arterial hypertension, plexiform lesions are associated with severe arterial obstruction and right ventricular failure as discussed by the authors, and the structure and position of these lesions are investigated.
Journal ArticleDOI
Outpatient prescription of pulmonary vasodilator therapy to preterm children with bronchopulmonary dysplasia
TL;DR: In this paper , a descriptive national registry-based study of children <7 years who had been prescribed a pulmonary vasodilator during 2007-2017, were born preterm and classified as having bronchopulmonary dysplasia.